Peptides

Azido-dPEG®12-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Azido-dPEG®12-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of ESRRG antibody, catalog no. 70R-1940

Bis-dPEG®5-Acid is a PEG polymer categorised as homobifunctional PEG (X-PEG X). Used as a linker, bis-dPEG®5-Acid is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.

A synthetic peptide for use as a blocking control in assays to test for specificity of IDS antibody, catalog no. 70R-10208

A synthetic peptide for use as a blocking control in assays to test for specificity of TUBB6 antibody, catalog no. 70R-10057

A synthetic peptide for use as a blocking control in assays to test for specificity of TASP1 antibody, catalog no. 70R-4354

A synthetic peptide for use as a blocking control in assays to test for specificity of UCHL3 antibody, catalog no. 70R-3126

4-Formyl-Benzamido-dPEG®24-TFP Ester is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. 4-Formyl-Benzamido-dPEG®24-TFP Ester is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of SLC20A2 antibody, catalog no. 70R-7534

A synthetic peptide for use as a blocking control in assays to test for specificity of FLJ14803 antibody, catalog no. 70R-6988

ACTH (1-24) is a peptide hormone and neurotransmitter that belongs to the corticotropin-releasing factor family. It is also known as corticotropin-releasing hormone, adrenocorticotropic hormone, or CRH. ACTH binds to the ACTH receptor, which activates protein kinase A and cyclic AMP response element binding protein (CREB). Activation of these proteins leads to an increase in the production of cortisol. ACTH can be used as a research tool for studying ion channels and ligands. It can also be used as an antibody in cell biology research.

A synthetic peptide for use as a blocking control in assays to test for specificity of PPP1CA antibody, catalog no. 70R-2013

A synthetic peptide for use as a blocking control in assays to test for specificity of SEPT12 antibody, catalog no. 70R-5540

SARS Coronavirus is an enveloped virus containing 3 outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein takes part in the virus infection cycle and is the primary target of neutralizing antibodies. SARS Spike produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 219 amino acids (306-515 aa) and having a molecular mass of 24.7kDa.SARS Spike is fused to a 6 amino acid His tag at C-terminus and purified by proprietary chromatographic techniques. The formulation of the SARS Spike (306-515) solution (0.5mg/ml) contains Phosphate-Buffered Saline (pH 7.4) and 10% Glycerol. Biological Activity: Measured by its binding ability in a functional ELISA with Human ACE-2 (CAT# enz-1159).
One-Letter Formula: ADPRVVPSGD VVRFPNITNL CPFGEVFNAT KFPSVYAWER KKISNCVADY SVLYNSTFFS TFKCYGVSAT KLNDLCFSNV YADSFVVKGD DVRQIAPGQT GVIADYNYKL PDDFMGCVLA WNTRNIDATS TGNYNYKYRY LRHGKLRPFE RDISNVPFSP DGKPCTPPAL NCYWPLNDYG FYTTTGIGYQ PYRVVVLSFE LLNAPATVCG PKLHHHHHH

Fmoc-N-Amido-dPEG®6-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Fmoc-N-Amido-dPEG®6-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of MPP3 antibody, catalog no. 70R-2662

A synthetic peptide for use as a blocking control in assays to test for specificity of PNMA6A antibody, catalog no. 70R-10158

A synthetic peptide for use as a blocking control in assays to test for specificity of RGS13 antibody, catalog no. 70R-2712

A synthetic peptide for use as a blocking control in assays to test for specificity of KCNK3 antibody, catalog no. 70R-1536

Lipoamido-dPEG®12-Acid is a PEG molecule conjugated with a lipid moiety. Lipoamido-dPEG®12-Acid, conjugated to this lipid constituent, is very important especially in drug delivery and vaccine development as it helps improve the stability and circulation time of lipid nanoparticles (LNPs) and liposomes.

A synthetic peptide for use as a blocking control in assays to test for specificity of TMPRSS6 antibody, catalog no. 70R-4605

A synthetic peptide for use as a blocking control in assays to test for specificity of FNDC8 antibody, catalog no. 70R-9464

A synthetic peptide for use as a blocking control in assays to test for specificity of UNC45A antibody, catalog no. 70R-9380

Peroxiredoxin-2 is a protein that belongs to the peroxidase family of enzymes. It has been shown to be an activator of ion channels, which suggests that it may play a role in cell regulation. Peroxiredoxin-2 has also been shown to bind to peptides and antibodies, with potential therapeutic applications.

A synthetic peptide for use as a blocking control in assays to test for specificity of ETV1 antibody, catalog no. 70R-7876

D-Ala2,Met5]-Enkephalinamide is a potent endogenous opioid peptide that binds to opioid receptors and has been shown to have both antinociceptive and depressant effects. It has been shown to be effective in a model system of pain, acting on the descending antinociceptive pathway from the rostral ventromedial medulla (RVM) to the spinal cord. D-Ala2,Met5]-Enkephalinamide has also been observed to inhibit locomotor activity in CD1 mice at sub-effective doses. D-Ala2,Met5]-Enkephalinamide has been shown to act through activation of both G protein-coupled mu opioids receptors and G protein-coupled delta opioid receptors.

Lipoamido-dPEG®4-Acid is a PEG molecule conjugated with a lipid moiety. Lipoamido-dPEG®4-Acid, conjugated to this lipid constituent, is very important especially in drug delivery and vaccine development as it helps improve the stability and circulation time of lipid nanoparticles (LNPs) and liposomes.

Z-Ala-Ala-Asn-AMC is a peptide that can be used as an inhibitor, activator, or ligand for protein interactions. It is also a research tool and antibody production reagent. This compound has high purity and is suitable for both in vitro and in vivo research.

A synthetic peptide for use as a blocking control in assays to test for specificity of GABBR2 antibody, catalog no. 70R-10243

A synthetic peptide for use as a blocking control in assays to test for specificity of RUNDC2A antibody, catalog no. 20R-1267

A synthetic peptide for use as a blocking control in assays to test for specificity of UNCX antibody, catalog no. 70R-8702

A synthetic peptide for use as a blocking control in assays to test for specificity of C17orf39 antibody, catalog no. 70R-2926

A synthetic peptide for use as a blocking control in assays to test for specificity of TIA1 antibody, catalog no. 70R-5035

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF675 antibody, catalog no. 70R-9564

A synthetic peptide for use as a blocking control in assays to test for specificity of C10orf57 antibody, catalog no. 70R-7192

A synthetic peptide for use as a blocking control in assays to test for specificity of KCNN1 antibody, catalog no. 70R-1492

A synthetic peptide for use as a blocking control in assays to test for specificity of SAR1B antibody, catalog no. 70R-3167

A synthetic peptide for use as a blocking control in assays to test for specificity of GCLC antibody, catalog no. 70R-9275

Portion of Influenza NP

A synthetic peptide for use as a blocking control in assays to test for specificity of PSMB1 antibody, catalog no. 70R-2340

A synthetic peptide for use as a blocking control in assays to test for specificity of DNM1 antibody, catalog no. 70R-2341

A synthetic peptide for use as a blocking control in assays to test for specificity of WBSCR1 antibody, catalog no. 70R-1353

A synthetic peptide for use as a blocking control in assays to test for specificity of Urgcp antibody, catalog no. 70R-9383

A synthetic peptide for use as a blocking control in assays to test for specificity of KLHL14 antibody, catalog no. 20R-1092

Lipoamido-dPEG®24-Acid is a PEG molecule conjugated with a lipid moiety. Lipoamido-dPEG®24-Acid, conjugated to this lipid constituent, is very important especially in drug delivery and vaccine development as it helps improve the stability and circulation time of lipid nanoparticles (LNPs) and liposomes.

A synthetic peptide for use as a blocking control in assays to test for specificity of GOLGA5 antibody, catalog no. 70R-6969

A synthetic peptide for use as a blocking control in assays to test for specificity of TPH2 antibody, catalog no. 70R-2005